Journals / Türk Toraks Dergisi / 2013 / Cilt: 14 - Sayı: 1

Etiology and epidemiology of community-acquired pneumonia in Turkey

Türkiye’de toplum kökenli pnömoni etyoloji ve epidemiyolojisi

Pages
5–10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The data obtained were in conformity with the results of the literature in general.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: Due to its prevalence and mortality, Community Acquired Pneumonia (CAP) poses a significant health issue.
📊
Key Findings & Data:The following tests were used for agent identification: (phlegm) Gram’s Stain and culture for bacteria, (serum) indirect immunofluorescent test for M. pneumoniae and Chlamydia pneumoniae, Enzyme Immuno Assay test for respiratory tract viruses, (urine) Antigen Enzyme Immune Assay test for Legionella pneumophila serogroup I antigen.
💡
Conclusion & Impact:The data obtained were in conformity with the results of the literature in general.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVES: Due to its prevalence and mortality, Community Acquired Pneumonia (CAP) poses a significant health issue. Epidemiological data is crucial in deciding empirical treatment. Since sufficient knowledge of CAP epidemiology is not available in Turkey, this study has been planned. Material and Methods: Seventy-two cases were assessed prospectively. The following tests were used for agent identification: (phlegm) Gram’s Stain and culture for bacteria, (serum) indirect immunofluorescent test for M. pneumoniae and Chlamydia pneumoniae, Enzyme Immuno Assay test for respiratory tract viruses, (urine) Antigen Enzyme Immune Assay test for Legionella pneumophila serogroup I antigen. Results: The rate at which the etiologic agent was reached was found to be 77.8%. While the viruses were the most frequent infection agent (57.1%), the rate of the presence of mixed infection of other agents with viruses was 48.2%. Agents that were observed to be a single pathogen were; Influenzae A virus (6.9%), C. pneumoniae (28.6%), M. pneumoniae (25.0%), S. pneumoniae (10.7%), H. influenzae ve M. catarrhalis (7.1%), with respect to their prevalence. Mortality rate was 10.4%. Conclusion: In addition to the high viral etiology rate, the prevalence of mixed infection is of concern. While, as the responsible agent, S. pneumoniae was lower than expected, the fact that C. pneumoniae and M. pneumoniae had higher rates suggest s the necessity of bearing in mind the atypical pneumonia agents during the treatment. The data obtained were in conformity with the results of the literature in general.

Özet

Amaç: Sık görülmesi ve mortalite sebebi olması nedeniyle Toplum Kökenli Pnömoni (TKP) önemli bir sağlık sorunudur. Ampirik tedavi kararında epidemiyolojik veriler kritik öneme sahiptir. Türkiye’de TKP epidemiyolojisine ait yeterli bilgi olmaması nedeniyle çalışma planlandı. Gereç ve Yöntemler: Yetmiş iki olgu prospektif olarak değerlendirildi. Etken identifikasyonunda bakteriler için (balgam) gram boyası ve kültür, M. pneumoniae ve Chlamydia pneumoniae için (serum) indirekt immunofluoresan testi, solunum yolu virusları için enzim immun assay testi, Legionella pneumophila serogrup I antijen için (idrar) Antijen Enzym Immun Assay testi yapıldı. Bulgular: Etyolojik ajana ulaşma oranı %77.8’dir. Viruslar en sık infeksiyon etkeni (%57.1) iken, viruslarla birlikte diğer etken- lerin mikst infeksiyon yapma oranı %48.2 dir. Tek patojen olarak saptanan etkenler sıklık sırasına göre; İnfluenzae A virüs (%6.9), C. pneumoniae (%28.6), M. pneumoniae (%25.0), S. pneumoniae (%10.7), H. influenzae ve M. catarrhalis (%7.1) dir. Mortalite oranı %10.4 dür. Sonuç: Viral etiyolojinin yüksek oranı yanında miks infeksiyon sıklığının yüksekliği dikkat çekicidir. Sorumlu etken olarak S. pneumoniae beklenenden daha düşük oranda iken, C. pneumoniae ve M. pneumoniae’ nın yüksek oranda saptanması tedavide atipik pnömoni etkenlerinin göz ardı edilmemesi gerektiğini ortaya koymaktadır. Elde edilen veriler genel olarak literatür sonuçları ile uyumludur.

🔖

Cite This Article

SEVER, F., KÖMÜS, N., ESEN, N., GÜNDÜZ, A. T., ÖKTEM, M. A., ÇIMRIN, A. H. (2013). Etiology and epidemiology of community-acquired pneumonia in Turkey. Türk Toraks Dergisi, Cilt: 14 - Sayı: 1, 5–10. https://ajindex.com/articles/329483

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Özlü T, Bülbül Y, Özsu S. Ulusal verilerle toplum kökenli pnö moniler. Tüberküloz ve Toraks Dergisi 2007
  2. Acar A, Öncül O. Toplum Kökenli Pnömoniler. Klimik Dergisi 2007
  3. Diaz A, Barria P, Niederman M, et al. Etiology of community acquired pneumonia in hospitalized patients in Chile: The inc reasing prevalence of respiratory viruses among classic patho gens. Chest 2007
  4. [CrossRef] 4.File TM. Community-Acquired Pneumonia. Lancet 2003
  5. [CrossRef] 5.Niederman MS. Recent advances in community-acquired pneumo nia: Inpatient and outpatient. Chest 2007
  6. [CrossRef] 6.Woodhead M, Blasi F, Ewig S, et al. ERS Task Force in Collabo ration With ESCMID. Guidelines for the management of adult lower respiratory tract infections. Eur respir J 2005
  7. [CrossRef] 7.Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Dise ases Society of America/American Thorasic Society consensus guidelines on the management of community-acquired pneu monia in adults. Clin Infect Dis 2007
  8. [CrossRef] 8.File TM, Garau J, Blasi F, et al. Guidlines for empiric antimic robial prescribing in community-acquired pneumonia. Chest 2004
  9. [CrossRef] 9.Toraks Derneği, Erişkinlerde toplum kökenli pnömoni: tanı ve tedavi rehberi. 2002 10.Cunha BA. Empiric therapy of community-acquired pneumo nia. Chest 2004
  10. [CrossRef] 11.Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumo nia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001
  11. Pizzichini E, Pizzichini MM, Hargreave FE. Induced sputum in the management of asthma. Seminars in Respir Crit Care Med 1998
  12. [CrossRef] 13.Kalin M, Lindberg AA, Tunevall G. Etiological diagnosis of bac terial pneumonia by Gram stain and quantitative culture of ex pectorates. Scand J Infect Dis 1983
  13. Koneman EW, Allen SD, Jonda WM, et al. The role of the mic robiology laboratory in the diagnosis of infectious diseases. Gi udelines to practice and management. In color atlas and text book of diagnostic microbiyology, fifthy ed. JB. Lippincott Com pany: Philadelphia. 1997
  14. Çilli A, Özdemir T, Öğüş C, Kara A. Ciddi toplum kökenli pnö monide etyoloji ve prognostik faktörler. Tüberküloz ve Toraks Dergisi 2001
  15. Menendez R, Torres A, Zalacain R, et al. Guidelines for the treatment of Community-acquired pneumon